Stockreport

How The Legend Biotech (LEGN) Story Is Shifting As Analyst Expectations Reset [Yahoo! Finance]

Legend Biotech Corporation - American Depositary Shares  (LEGN) 
PDF Legend Biotech's updated analyst narrative now reflects a modest reset in expectations, with fair value revised from US$58.70 to US$57.22. This change aligns with recen [Read more]